Search Results

You are looking at 91 - 100 of 167 items for :

  • "ampicillin" x
  • Refine by Access: All Content x
Clear All
Acta Veterinaria Hungarica
Authors:
Ana Carolina Valentim Hespanha
,
Bruno Watanabe Minto
,
Marita Vedovelli Cardozo
,
Mareliza Possa De Menezes
,
Júlia Banhareli Tasso
, and
Paola Castro Moraes

antimicrobials were chosen from the main antimicrobial drugs used in clinical and surgical routine, and were the following: ampicillin (10 μg), ampicillin with sulbactam (20 μg), amoxicillin (20 μg), amoxicillin with clavulanic acid (10 μg), gentamicin (10 μg

Restricted access

testing Antibiotic susceptibility testing was performed by E-test (BioMérieux), as described previously [ 16 ]. Seventeen antimicrobial agents, ampicillin, amoxicillin-clavulanic acid, cefotaxime, ceftriaxone, cefepime, imipenem, clarithromycin, gentamicin

Restricted access
Acta Microbiologica et Immunologica Hungarica
Authors:
Samira Amereh
,
Fatemeh Zeynali Kelishomi
,
Fatemeh Ghayaz
,
Amir Javadi
,
Amir Peymani
,
Fatemeh Fardsanei
,
Ehsan Aali
, and
Farhad Nikkhahi

. The antibiotic disks (Mast Group, Merseyside, UK) used in our study were as follows: ampicillin (10 μg), cefoxitin (30 μg), ceftazidime (30 μg), ceftazidime-clavulanate (10/10 μg), cefotaxime (30 μg), cefotaxime-clavulanate (10/30 μg), cefuroxime (30

Restricted access

), clindamycin (2 µg), vancomycin (30 µg), ampicillin (30 µg), chloramphenicol (30 µg), tetracycline (30 µg), cefotixin (30 µg), rifampicin (5 µg), and oxacillin (1 µg) were used. The breakpoints of Staphylococcus and Enterococcus species resistance were used

Open access

penicillins (ampicillin, ampicillin-sulbactam, oxacillin, and piperacillin–tazobactam), cephalosporins (3rd and 4th generation cephalosporins, as well as cefuroxime and cefoxitin), the carbapenem imipenem, fluoroquinolones (norfloxacin, ciprofloxacin

Open access

automated susceptibility system, following the guidelines of the Clinical & Laboratory Standards Institute guidelines (CLSI). The agents tested included amikacin (AMK), ampicillin/sulbactam (AMS), cefoperazone/sulbactam (CFP/SUL), cefepime (FEP), ceftazidime

Open access

antimicrobial agents, ampicillin/sulbactam (10/10 µg), meropenem (10 μg), gentamicin (10 μg), doxycycline (30 µg), ciprofloxacin (5 μg), co-trimoxazole (1.25/23.75 μg), cefepime (30 μg), ceftazidime (30 μg), and levofloxacin (30 μg) (Mast, UK). Results were

Restricted access

(%) (%) (%) (%) (%) (%) (%) (%) Ampicillin 100 0 0 0 96.4 0 3.6 0 Amoxicillin Clavulante 100 0 0 0 98.2 0 0.9 0.9 Amikacin 99.1 0.9 0 0 98.2 1.8 0 0 Cefixime 100 0 0 0 100 0 0 0 Ciprofloxacin 95.5 2.7 0 1.8 93.7 2.7 0 3.6 Ceftriaxone 100 0 0 0 99.1 0 0.9 0 Cefuroxime 100 0 0 0 96.4 0 2.7 0

Restricted access

(MIC ≤0.02 mg/mL), ampicillin (MIC 0.032 mg/mL), meropenem (MIC 0.012 mg/mL), ceftriaxone (MIC 0.08 mg/mL), metronidazole (MIC 0.75 mg/mL), clindamycin (MIC <0.016 mg/mL), and piperacillin/tazobactam (MIC 0.064 mg/mL), cefoxitin (MIC 0.094 mg

Restricted access

. Antimicrobial susceptibility testing Antimicrobial susceptibilities to ampicillin, amoxicillin/clavulanic acid (AMC), amikacin, fosfomycin, gentamicin, imipenem, nalidixic acid, nitrofurantoin, norfloxacin, cefazolin, cefuroxime, ceftriaxone, cefotaxime

Restricted access